At 16.6% CAGR, the Asia Pacific Bariatric Surgeries Market is Projected to be Worth US$ 3,115.01 Million by 2030, Says Business Market Insights

According to Business Market Insights' research, the Asia Pacific bariatric surgeries market was valued at US$ 913.53 in 2022 and is expected to reach US$ 3,115.01 million by 2030, registering a CAGR of 16.6% from 2022 to 2030. Growing demand for minimally invasive surgeries and increasing prevalence of obesity are among the critical factors attributed to the Asia Pacific bariatric surgeries market expansion.

Over a period of time, there has been significant growth in the prevalence of chronic disorders, leading to an increase in surgical procedures. Invasive surgical procedures have high risk factors, and patients take longer time in recovery. These procedures have a high risk of infections and a high rate of complications on a global level. To overcome the consequences associated with invasive procedures, minimally invasive procedures are preferred by healthcare professionals. Healthcare professionals are more inclined toward minimally invasive procedures due to various advantages such as shorter recovery periods, very limited to no complications, high success rates, and reduction in procedure time.

The positive outcomes of minimally invasive surgeries have increased the inclination toward minimally invasive bariatric surgeries as market players are focused on development and launch of advanced products. Nowadays, several minimally invasive bariatric surgeries are performed, including laparoscopic gastric bypass, laparoscopic sleeve gastrectomy, and laparoscopic gastric binding. As per the National Health Institutes 2022 report, nowadays, ~90% of gastric bypasses are done laparoscopically, with a death rate of 0.22%, which is less than 0.82% for open surgery. Each procedure has its own advantages and disadvantages, and the choice will depend upon the medical history and patient needs. Moreover, the rising inclination toward non-invasive bariatric devices is expected to proliferate the market growth. There are various manufacturers focused on the development of gastric balloons, which can be placed into the stomach through endoscopy procedures and can be easily removed when required. These balloons have limited to no side effects with positive outcomes. Therefore, the surge in minimally invasive bariatric surgeries, the launch and development of specialized instruments, and positive patient outcomes contribute to the growth of the bariatric surgery devices market.

On the contrary, stringent regulatory policies and increase in safety concerns hamper the growth Asia Pacific bariatric surgeries market .

Based on type, the Asia Pacific bariatric surgeries market is segmented adjustable gastric bands (AGB), sleeve gastrectomy, gastric bypass, biliopancreatic diversion with duodenal switch (BPD- DS), and others. The sleeve gastrectomy market segment held 67.7% share of the Asia Pacific bariatric surgeries market in 2022, amassing US$ 618.67 million. It is projected to garner US$ 2,165.54 million by 2030 to expand at 17.0% CAGR during 2022-2030.

By end user, the Asia Pacific bariatric surgeries market is bifurcated into hospitals and ambulatory surgical centers. The hospital segment held 68.6% share of Asia Pacific bariatric surgeries market in 2022, amassing US$ 626.23 million. It is projected to garner US$ 2,046.15 million by 2030 to expand at 16.0% CAGR during 2022-2030.

Based on country, the Asia Pacific bariatric surgeries market is categorized into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China held 29.8% share of Asia Pacific bariatric surgeries market in 2022, amassing US$ 272.68 million. It is projected to garner US$ 997.56 million by 2030 to expand at 17.6% CAGR during 2022-2030.

Key players operating in the Asia Pacific bariatric surgeries market are Conmed Corp, Integra LifeSciences Holdings Corp, Intuitive Surgical Inc, Medtronic Plc, Olympus Corp, and Reshape Lifesciences Inc, among others.

- In February 2020, Medtronic plc acquired Digital Surgery, a privately held pioneer in surgical artificial intelligence (AI), data and analytics, and digital education and training. The acquisition of Digital Surgery will strengthen the Medtronic robotic assisted surgery platform and will expand Medtronic's product portfolio.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com